21 May, 2024 Endovascular Shunting for Communicating Hydrocephalus Using a Biologically Inspired Transdural Cerebrospinal Fluid Valved eShunt® Implant Admin2024-10-15T17:42:20+00:00May 21st, 2024|Tags: Neurosurgery Clinics of North America| Read More
13 May, 2024 CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus Admin2024-05-28T21:41:18+00:00May 13th, 2024| Read More
07 May, 2024 CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus cerevasc2024-05-28T21:43:24+00:00May 7th, 2024| Read More
